Davis Tahnil R.
Known title: Chief Accounting Officer & EVPCIK: 0002109272
Associated companies
Transaction History
| TTD | ▲ Buy | Grant | 217,233 | $0 | 9/14/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 1,220 | $17K | 8/15/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 5,317 | $75K | 8/15/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 1,373 | $19K | 8/15/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 1,051 | $15K | 8/15/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 262 | $6K | 5/15/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 861 | $18K | 5/15/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 741 | $16K | 5/15/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 968 | $20K | 5/15/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 3,750 | $79K | 5/15/2026 | View on chart |
| TTD | ▲ Buy | Grant | 167,197 | $0 | 3/3/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 603 | $16K | 2/15/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 301 | $8K | 2/15/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 887 | $23K | 2/15/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 741 | $19K | 2/15/2026 | View on chart |
| TTD | ▼ Sell | Tax Withholding | 968 | $25K | 2/15/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
TTD down 77% while market rises; healthcare integration news
The Trade Desk shares have fallen 77% while the broader market has risen, leading to comparisons with other ad-tech stocks like Alphabet and AppLovin. Recent news highlights a healthcare inventory integration with OptimizeRx, which may be relevant to its advertising capabilities. Despite the significant price drop, the stock trades at a trailing P/E of 13.8, well below its 52-week high of $56.39.
TTD down 77% while market rises; healthcare integration news. The Trade Desk shares have fallen 77% while the broader market has risen, leading to comparisons with other ad-tech stocks like Alphabet and AppLovin. Recent news highlights a healthcare inventory integration with OptimizeRx, which may be relevant to its advertising capabilities. Despite the significant price drop, the stock trades at a trailing P/E of 13.8, well below its 52-week high of $56.39.